<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>Study outcome measures</p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td align="left" valign="bottom" rowspan="1" colspan="1">Primary outcomes: Embedded feasibility pilot</td>
    <td align="left" valign="bottom" rowspan="1" colspan="1">
     <list list-type="order">
      <list-item>
       <p>Compliance to randomised arm</p>
      </list-item>
      <list-item>
       <p>Recruitment and randomisation rate</p>
      </list-item>
      <list-item>
       <p>Safety (adverse events)</p>
      </list-item>
      <list-item>
       <p>Proportion of patients with complete pathological response on post-SOC systemic therapy prostate biopsies at 6–9 months</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Primary outcomes: Phase II</td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <list list-type="order">
      <list-item>
       <p> Progression-free survival (PFS)</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Secondary outcomes: Phase II</td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <list list-type="order">
      <list-item>
       <p> Urinary, sexual and rectal side effects</p>
      </list-item>
      <list-item>
       <p> Patient-reported outcomes using validated questionnaires</p>
      </list-item>
      <list-item>
       <p> Progression on PSA and imaging and impact of clinical features on progression</p>
      </list-item>
      <list-item>
       <p> Health-related quality of life</p>
      </list-item>
      <list-item>
       <p> Data on costs and resource utilisation for future cost-effectiveness analysis</p>
      </list-item>
     </list>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="T2_FN1">
   <p>OS, overall survival; PSA, prostate-specific antigen.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
